These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 12683237)
1. [Effect of etoposide and amsacrine on mitotic progression of GM-130 and Hep-2 cell lines. The flow cytometry assay]. Shatrova AN; Aksenov ND; Poletaev AI; Zenin VV Tsitologiia; 2003; 45(1):59-68. PubMed ID: 12683237 [TBL] [Abstract][Full Text] [Related]
2. [Flow cytometric analysis of ICRF-193 influence on cell passage through mitosis]. Shatrova A; Aksenov ND; Zenin VV Tsitologiia; 2002; 44(11):1068-78. PubMed ID: 12561727 [TBL] [Abstract][Full Text] [Related]
3. Application of fluorescence in situ hybridisation to study the relationship between cytotoxicity, chromosome aberrations, and changes in chromosome number after treatment with the topoisomerase II inhibitor amsacrine. Ferguson LR; Whiteside G; Holdaway KM; Baguley BC Environ Mol Mutagen; 1996; 27(4):255-62. PubMed ID: 8665870 [TBL] [Abstract][Full Text] [Related]
4. Novobiocin, nalidixic acid, etoposide, and 4'-(9-acridinylamino)methanesulfon-m-anisidide effects on G2 and mitotic Chinese hamster ovary cell progression. Rowley R; Kort L Cancer Res; 1989 Sep; 49(17):4752-7. PubMed ID: 2474373 [TBL] [Abstract][Full Text] [Related]
5. Effect of cell cycle on the regulation of the cell surface and secreted forms of type I and type II human tumor necrosis factor receptors. Pocsik E; Mihalik R; Penzes M; Loetscher H; Gallati H; Aggarwal BB J Cell Biochem; 1995 Nov; 59(3):303-16. PubMed ID: 8567749 [TBL] [Abstract][Full Text] [Related]
6. Effect of cellular ATP depletion on topoisomerase II poisons. Abrogation Of cleavable-complex formation by etoposide but not by amsacrine. Sorensen M; Sehested M; Jensen PB Mol Pharmacol; 1999 Mar; 55(3):424-31. PubMed ID: 10051525 [TBL] [Abstract][Full Text] [Related]
7. Psammaplin A, a natural phenolic compound, has inhibitory effect on human topoisomerase II and is cytotoxic to cancer cells. Kim D; Lee IS; Jung JH; Lee CO; Choi SU Anticancer Res; 1999; 19(5B):4085-90. PubMed ID: 10628358 [TBL] [Abstract][Full Text] [Related]
8. Cell cycle traverse in AHH-1 tk +/- human lymphoblastoid cells exposed to the chromosomal mutagen, m-amsa. Morris SM; McGarrity LJ; Domon OE; Chen JJ; Casciano DA Environ Mol Mutagen; 1996; 27(1):10-8. PubMed ID: 8625943 [TBL] [Abstract][Full Text] [Related]
9. Topoisomerase II inhibitors affect entry into mitosis and chromosome condensation in BHK cells. Anderson H; Roberge M Cell Growth Differ; 1996 Jan; 7(1):83-90. PubMed ID: 8788036 [TBL] [Abstract][Full Text] [Related]
10. Differential cell cycle-specificity for chromosomal damage induced by merbarone and etoposide in V79 cells. Wang L; Roy SK; Eastmond DA Mutat Res; 2007 Mar; 616(1-2):70-82. PubMed ID: 17174356 [TBL] [Abstract][Full Text] [Related]
11. Design of two etoposide-amsacrine conjugates: topoisomerase II and tubuline polymerization inhibition and relation to cytotoxicity. Arimondo P; Boukarim C; Bailly C; Dauzonne D; Monneret C Anticancer Drug Des; 2000 Dec; 15(6):413-21. PubMed ID: 11716434 [TBL] [Abstract][Full Text] [Related]
13. [Incidence of mutation and deletion in topoisomerase II mRNA of etoposide and m-AMSA resistant cell lines]. Matsumoto Y; Morisaki K; Kunishio K; Nagao S; Takano H; Fojo T Gan To Kagaku Ryoho; 1998 Jul; 25(8):1145-9. PubMed ID: 9679576 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of genistein and amsacrine on leukemia cell proliferation. Finlay GJ; Holdaway KM; Baguley BC Oncol Res; 1994; 6(1):33-7. PubMed ID: 7919550 [TBL] [Abstract][Full Text] [Related]
15. Enhanced amsacrine-induced mutagenesis in plateau-phase Chinese hamster ovary cells, with targeting of +1 frameshifts to free 3' ends of topoisomerase II cleavable complexes. Patteson K; Wang P; Povirk LF Cancer Res; 1999 Aug; 59(15):3682-8. PubMed ID: 10446982 [TBL] [Abstract][Full Text] [Related]
16. The cell cycle phases of DNA damage and repair initiated by topoisomerase II-targeting chemotherapeutic drugs. Potter AJ; Rabinovitch PS Mutat Res; 2005 May; 572(1-2):27-44. PubMed ID: 15790488 [TBL] [Abstract][Full Text] [Related]
17. Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Walker PR; Smith C; Youdale T; Leblanc J; Whitfield JF; Sikorska M Cancer Res; 1991 Feb; 51(4):1078-85. PubMed ID: 1847655 [TBL] [Abstract][Full Text] [Related]
18. Inhibitors of topoisomerase II delay progress through mitosis and induce a doubling of the DNA content in CHO cells. Sumner AT Exp Cell Res; 1995 Apr; 217(2):440-7. PubMed ID: 7698244 [TBL] [Abstract][Full Text] [Related]
19. Changes of mitochondrial mass in the hemopoietic stem cell line FDCP-mix after treatment with etoposide: a correlative study by multiparameter flow cytometry and confocal and electron microscopy. Reipert S; Berry J; Hughes MF; Hickman JA; Allen TD Exp Cell Res; 1995 Dec; 221(2):281-8. PubMed ID: 7493625 [TBL] [Abstract][Full Text] [Related]
20. Can nocodazole, an inhibitor of microtubule formation, be used to synchronize mammalian cells? Accumulation of cells in mitosis studied by two parametric flow cytometry using acridine orange and by DNA distribution analysis. Nüsse M; Egner HJ Cell Tissue Kinet; 1984 Jan; 17(1):13-23. PubMed ID: 6692463 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]